Stephen L. Sabba

Stephen L. Sabba is a board member at ILiAD Biotechnologies. Stephen has also served as a director at QLT Inc., Ligand Pharmaceuticals, Dorset Management, and Kilkenny Capital. Prior to their current role, Sabba was the head of research at Sturza Medical Research.

Sabba has over 20 years of experience in the healthcare industry. Stephen began their career as a health care analyst at Kilkenny Capital in 2001. Stephen quickly rose through the ranks and became a partner at the firm in 2006.

In 2012, Sabba left Kilkenny Capital to join QLT Inc. as a director. Stephen held this position for four years before moving on to Ligand Pharmaceuticals in 2016. Sabba served as a director at Ligand for less than a year before joining ILiAD Biotechnologies as a board member.

Dr. Stephen L. Sabba is a medical doctor who specializes in internal medicine. Stephen attended Cornell University for their undergraduate degree in biology and behavioral science, and then went on to complete their MD at New York Medicine Jobs.